Expression of human beta-defensins-1, 2 and 4 mRNA in human lung tumor tissue: A pilot study

Experimental Oncology

Volumn 30, Issue 2, 2008, Pages 153-156

  Shestakova, T ^a   Zhuravel, E ^a   Bolgova, L ^b   Alekseenko, O ^b   Soldatkina, M ^a   Pogrebnoy, P ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b NATIONAL CANCER INSTITUTE   (Ukraine)

Author keywords

Expression; Human beta defensin; Human lung tumors

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 4; MESSENGER RNA;

ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG TUMOR; PILOT STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

BETA-DEFENSINS; CELL LINE, TUMOR; COHORT STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PILOT PROJECTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 46749145002     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lehrer RI. Primate defensins. Nat Rev Microbiol 2004; 2: 727-38.
2. Yang D, Chertov O, Bikovskaya SN, et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T-cell CCR6. Science 1999; 286: 525-8.
3. Bowdish DME, Davidson DJ, Hancock REW. Immunomodulatory properties of defensins and catelicidins. Curr Top Microbiol Immunol 2006; 306: 27-66.
4. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2002; 14: 96-102.
5. Hiratsuka T, Mukae H, Iiboshi H, et al. Increased concentrations of human beta defensins in plasma and bron-choalvealar lavage in patients with diffuse panbronchiolytis. Thorax 2003; 58: 425-30.
6. Stolzenberg ED, Anderson GM, Ackermann MR, et al. Epithelial antibiotic induced at states of disease. Proc Natl Acad Sci USA 1997; 94: 8686-90.
7. Harder J, Meyer-Hoffert U, Teran LM, et al. Mucoid Pseudomonas aeruginosa, TNF-alpha and ILI-beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Mol Cel Biol 2000; 22: 714-21.
8. Rogan MP, Geraghty P, Greene CM, et al. Antimicrobial proteins and polypeptides in pulmonary innate defense. Resp Research 2006; 7: 29.
9. Mukae H, Ishimoto H, Yanagi S, et al. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis. Respir Med 2007; 101: 715-21.
10. Arimura Y, Ashitani J, Yanagi S, et al. Elevated serum beta-defensins concentrations in patients with lung cancer. Anticancer Res 2004; 24: 4051-7.
11. Markeeva N, Lisovskiy I, Zhuravel E, et al. Involvement of human beta-defensin-2 in proliferation of transformed cells of human cervix. Exp Oncol 2005; 27: 308-14.
12. Shnitsar VM, Lisovskiy IL, Nespryadko SV, et al. Human beta-defensin 3 (hBD-3) expression in A431 cell line and human vulvae tumors. Exp Oncol 2004; 26: 328-31.
13. Markeeva N, Lisovskiy I, Lyzogubov V, et al. Expression of beta-defensin-2 in human gastric tumors: a pilot study. Exp Oncol 2005; 27: 130-5.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
15. Sawaki K, Mizukawa N, Yamaai T, et al. High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 2002; 22: 2103-7.
16. Albrethsen J, Bogebo R, Gammeltoft S, et al. Up-regulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer 2005; 5: 8.
17. Donald CD, Sun SQ, Lim SD, et al. Cancer-specific loss of human beta-defensin-1 in human renal and prostatic carcinomas. Lab Invest 2003; 83: 501-5.
18. Bullard RS, Gibson W, Bose SK, et al. Functional analysis of the host defense peptide human beta-defensin-1: new insight into its potential role in cancer. Mol Immunol 2008; 45: 839-48.
19. Biragyn A, Ruffini PA, Leifer CA, et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin-2. Science 2002; 298: 1025-9.